Incyte (NASDAQ:INCY) was given a new $103.00 price target on by analysts at Truist Financial Corporation.
?????·???????·?????????????????????????????????????????????????? [CNET News]
Is It Too Late To Consider Incyte After A 45% Rally In 2025? [Yahoo! Finance]
The Bull Case For Incyte (INCY) Could Change Following New Minjuvi And Zynyz Approvals In Europe And Japan [Yahoo! Finance]
Incyte Japan Announces Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Anal Cancer [Yahoo! Finance]